Form 4: Arteris Inc. COO Sells Shares to Cover Tax Obligations and Under Pre-Arranged Trading Plan
SEC Form 4
Arteris Inc.'s Chief Operating Officer, Laurent R. Moll, sold shares to cover tax liabilities and under a pre-arranged trading plan.
Summary
- Laurent R. Moll, the Chief Operating Officer of Arteris Inc., sold 611 shares of common stock on December 3, 2024, at a price of $8.5783 per share.
- An additional 202 shares were sold on December 4, 2024, at a price of $8.64 per share.
- These transactions were made to cover tax liabilities arising from the release of restricted stock units and under a pre-arranged 10b5-1 trading plan adopted on March 15, 2024.
- Following these sales, Mr. Moll beneficially owns 491,592 shares of Arteris Inc. common stock.
- This total includes 3,000 shares acquired on November 21, 2024, through the company's Employee Stock Purchase Plan.
Sentiment
Score: 5
Explanation: The document reflects routine insider trading activity for tax purposes and under a pre-arranged plan, which is neither positive nor negative for the company's overall outlook.
Risks
- Insider selling, even for tax purposes, can sometimes be perceived negatively by the market.
Industry Context
This is a routine disclosure of insider trading activity, which is common for executives of publicly traded companies. The use of a 10b5-1 trading plan is a standard practice to avoid accusations of trading on inside information.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, such as those in the semiconductor and technology sectors, including companies like ARM Holdings and Synopsys.
- These plans allow for scheduled sales of stock to avoid accusations of insider trading, and are often used to manage tax liabilities related to stock-based compensation.
- The reported sales are relatively small in comparison to the total shares held by the executive, which is typical for these types of transactions.
Stakeholder Impact
- The sales may have a minor impact on the stock price, but are unlikely to significantly affect shareholder value given the relatively small volume of shares sold.
Key Dates
| Date | Description |
|---|---|
| 2024-03-15 | Date the 10b5-1 trading plan was adopted by Laurent R. Moll. |
| 2024-11-21 | Date Laurent R. Moll acquired 3,000 shares through the Employee Stock Purchase Plan. |
| 2024-12-03 | Date of the first reported sale of 611 shares. |
| 2024-12-04 | Date of the second reported sale of 202 shares. |
| 2024-12-05 | Date the Form 4 was signed. |
Keywords
insider trading, stock sale, Form 4, Arteris Inc., Laurent R. Moll, 10b5-1 plan, executive compensation, tax liability, employee stock purchase plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.